Disclosures for "The Nature and Magnitude of Cognitive Impairment in Narcolepsy and Idiopathic Hypersomnia: A Meta-analysis"
-
Dr. Maruff has received personal compensation for serving as an employee of Cogstate .
-
Dr. Latzman has received personal compensation for serving as an employee of Takeda Pharmaceutical Company Limited. Dr. Latzman has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Personality Assessment. Dr. Latzman has stock in Takeda Pharmaceutical Company Limited.
-
Mr. Gattuso has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cogstate. Mr. Gattuso has received personal compensation in the range of $10,000-$49,999 for serving as a PhD Student with The University of Melbourne.
-
The institution of Dr. Plazzi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TAKEDA. The institution of Dr. Plazzi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOPROJET. The institution of Dr. Plazzi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for JAZZ. The institution of Dr. Plazzi has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for OREXIA. The institution of Dr. Plazzi has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for OREXIA/CENTESSA.
-
Dr. Scammell has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Takeda. Dr. Scammell has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for UpToDate. The institution of Dr. Scammell has received research support from Takeda.
-
Brian Harel has received personal compensation for serving as an employee of Takeda. An immediate family member of Brian Harel has received personal compensation for serving as an employee of Astra Zeneca. Brian Harel has stock in Takeda, Merck, Day One Biopharmaceuticals. An immediate family member of Brian Harel has stock in Eli Lilly, Pfizer, Astra Zeneca. Brian Harel has stock in Cogstate.